周五盘中，Guardian Pharmacy Services, Inc.（股票代码：GRDN）股价大跌5.14%，投资者对公司最新公布的2024财年业绩报告反应强烈。
根据Guardian Pharmacy Services发布的财报显示，公司2024财年净亏损达1.10亿美元，同比大幅增加560.25%。尽管公司营业收入同比增长17.40%至12.28亿美元，但每股基本亏损达1.74美元，财务状况令人担忧。这一业绩表现明显低于市场预期，导致投资者信心受挫。
从资产负债表来看，Guardian Pharmacy Services的财务状况也不容乐观。公司总负债达1.85亿美元，其中短期债务为1062万美元。资产负债比高达1.82，而流动比率仅为1.06，显示公司面临一定的财务压力。尽管目前有3家机构给出的目标价均值为24.33美元，但考虑到公司业绩的大幅下滑，投资者对其未来发展前景产生了怀疑，导致股价承压下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.